全部

1·A series of 110 semiconsecutive clinical cases evaluated for lymphoma with historic flow cytometric (FCM) results were assessed with BRISH.

对一组有传统流式细胞仪（FCM）检测结果的110例淋巴瘤临床病例进行了BRISH评估。

2·BRISH light chain restriction (LCR) results were concordant with FCM in 108 (99%) of 109 evaluable cases. Additional small B-cell lymphoma cohorts were successfully evaluated.

在109例可评价的病例中，有108例(99%)BRISH检测轻链限制性(LCR)的结果与流式细胞仪一致，并成功评估了另外的小B细胞淋巴瘤病例组。